Positive response to trastuzumab in a case of HER2-overexpressing metastatic gastric cancer that presented as severe thrombocytopenia

Onkologie

Volumn 34, Issue 11, 2011, Pages 621-624

  Choi, Jae Hyun ^a   Han, Hye Suk ^a   Lee, Ho Chang ^a   Lee, Ok Jun ^a   Kim, Jeong Tae ^a   Lim, Sung Nam ^a   Lee, Ki Hyeong ^a   Kim, Seung Taik ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Gastric cancer; HER2; Thrombocytopenia; Trastuzumab

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA GLUTAMYLTRANSFERASE; HEMATOXYLIN; TRASTUZUMAB;

ABDOMINAL TENDERNESS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SMEAR; BONE MARROW BIOPSY; BRAIN HEMORRHAGE; CANCER CELL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ECCHYMOSIS; ENDOSCOPIC BIOPSY; ESOPHAGOGASTRODUODENOSCOPY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER DYSFUNCTION; MALE; OCCIPITAL LOBE; SIGNET RING CARCINOMA; SKIN EXAMINATION; STOMACH CANCER; STOMACH ULCER; STOMACH WALL; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; VISUAL DISORDER;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CARCINOMA; HUMANS; MALE; MIDDLE AGED; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; THROMBOCYTOPENIA; TREATMENT OUTCOME; UP-REGULATION;

EID: 81855184548     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000334055     Document Type: Article

References (13)

1. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50. (Pubitemid 46655601)
2. Ministry for Health, Welfare and Family Affairs: Annual Report of Cancer Incidence (2007), Cancer Prevalence (2007) and Survival (1993-2007) in Korea. Ministry for Health, Welfare and Family Affairs, 2009, pp. 14-17.
3. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE: Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006; 24:2903-9. (Pubitemid 46630593)
4. Gravalos C, Jimeno A: HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008;19:1523-9.
5. Tanner M, Hollmen M, Junttila TT, Kapanen AI, Tommola S, Soini Y, Helin H, Salo J, Joensuu H, Sihvo E, Elenius K, Isola J. Amplification of HER-2 in gastric carcinoma: association with topoisomerase II alpha gene amplification, intestinal type, poor prognosis and sensitivity to trastu-zumab. Ann Oncol 2005;16:273-8. (Pubitemid 40309309)
6. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overex-presses HER2. N Engl J Med 2001;344:783-92. (Pubitemid 32222155)
7. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK; for the ToGA Trial Investigators: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer. Lancet 2010; 376:687-97.
8. Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sánchez Rovira P, Piccart-Gebhart MJ; HERA study team: 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 2007;369:29-36. (Pubitemid 46039831)
9. Ross JS, McKenna BJ: The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001;19:554-68. (Pubitemid 32619394)
10. Tokar M, Bobilev D, Ariad S, Geffen DB: Disseminated intravascular coagulation at presentation of advanced gastric cancer. Isr Med Assoc J 2006;8:853-5. (Pubitemid 46017769)
11. Pasquini E, Gianni L, Aitini E, Nicolini M, Fattori P, Cavazzini G,Desiderio F, Monti F, Forghiere M, Ravaioli A: Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology 1995;52:505-8.
12. Yeh KH, Cheng AL: Gastric cancer associated with acute disseminated intravascular coagulation: successful initial treatment with weekly 24-hour infusion of high dose 5-fluorouracil and leucovorin. Br J Haematol 1998;100:769-72.
13. Inui T, Asakawa A, Morita Y, Mizuno S, Natori T, Kawaguchi A, Murakami M, Hishikawa Y, Inui A: HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer. J Intern Med 2006;260:484-7. (Pubitemid 44571137)